EP. 1: Transplant Eligibility, NCCN Recommendations, and Sequencing
Watch
EP. 2: Proteasome Inhibitor-Based Treatment Regimens
EP. 3: Treatment of Newly Diagnosed Symptomatic Myeloma and Dosing Regimens
EP. 4: Studies With a PI-Based Quadruplet Regimen and Sequencing
EP. 5: MRD Assessment and Prognostic Factors for Myeloma
EP. 6: Maintenance Therapy and Relapse/Refractory Treatment
EP. 7: Unmet Needs and the Future of Myeloma